Detrimental Changes in Health during Menopause: The Role of Physical Activity

Abstract

Midlife women experience changes in cardiometabolic, physical, and psychosocial health during menopause that negatively impacts their overall quality of life. Factors that contribute to these increases in cardiometabolic risk include weight gain as well as increases in fat mass (particularly abdominal adiposity), insulin resistance, and vascular dysfunction. Other deleterious changes in physical health (e. g. reduced sleep health, bone density, and balance) as well as changes in psychosocial health (e. g. mood, anxiety, and depression) often coincide and are linked to these increases in cardiometabolic risk. Physical activity and exercise are important lifestyle components that have been demonstrated to improve cardiometabolic, physical, and psychosocial health, yet physical activity and exercise is known to decline during perimenopause and into the postmenopausal years. In this narrative review, we summarize these changes in overall health during menopause as well as how declining physical activity contributes to these changes. Additionally, we discuss how incorporating physical activity and exercise during menopause can potentially ameliorate health declines. We conclude that there exists a significant, positive impact of physical activity on cardiometabolic, physical, and psychological health among midlife women, particularly if undertaken during the perimenopausal and postmenopausal years.

Key words

menopause - physical activity - exercise - metabolism - adiposity - insulin resistance

Publication History

Received: 29 July 2022

Accepted: 12 December 2022

Article published online:
17 February 2023

• References

• 1 El Khoudary SR, Aggarwal B, Beckie TM.. et al. Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association. Circulation 2020; 142: E506-E532
• 2 Davis S, Lambrinoudaki I, Lumsden M.. et al. Menopause. Nat Rev Dis Primers 2015; 1: 15004
• 3 Lovejoy JC, Champagne CM, De Jonge L. et al. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes 2008; 32: 949-958
• 4 Marlatt KL, Pitynski-Miller DR, Gavin KM. et al. Body composition and cardiometabolic health across the menopause transition. Obesity (Silver Spring) 2022; 30: 14-27
• 5 Schmid SM, Hallschmid M, Schultes B.. The metabolic burden of sleep loss. Lancet Diabetes Endocrinol 2015; 3: 52-62
• 6 Kravitz HM, Joffe H.. Sleep during the perimenopause: a SWAN story. Obstet Gynecol Clin North Am 2011; 38: 567-586
• 7 Greendale GA, Sowers M, Han W. et al. Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: results from the Study of Women’s Health Across the Nation (SWAN). J Bone Miner Res 2012; 27: 111-118
• 8 Bromberger JT, Kravitz HM, Chang YF. et al. Major depression during and after the menopausal transition: study of women’s health across the nation (SWAN). Psychol Med 2011; 41: 1879-1888
• 9 Cheng CC, Hsu CY, Liu JF.. Effects of dietary and exercise intervention on weight loss and body composition in obese postmenopausal women: a systematic review and meta-analysis. Menopause 2018; 25: 772-782
• 10 Harlow SD, Gass M, Hall JE. et al. Executive summary of the stages of reproductive aging workshop +10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab 2012; 97: 1159-1168
• 11 Wallace RB, Sherman BM, Bean JA. et al. Probability of menopause with increasing duration of amenorrhea in middle-aged women. Am J Obstet Gynecol 1979; 135: 1021-1024
• 12 Gold EB, Bromberger J, Crawford S. et al. Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol 2001; 153: 865-874
• 13 Gold EB, Crawford SL, Avis NE. et al. Factors related to age at natural menopause: longitudinal analyses from SWAN. Am J Epidemiol 2013; 178: 70-83
• 14 Harlow SD.. Menstrual cycle changes as women approach the final menses: what matters?. Obstet Gynecol Clin North Am 2018; 45: 599-611
• 15 Greendale GA, Sternfeld B, Huang MH. et al. Changes in body composition and weight during the menopause transition. JCI Insight 2019; 4: e124865
• 16 Soriguer F, Morcillo S, Hernando V. et al. Type 2 diabetes mellitus and other cardiovascular risk factors are no more common during menopause: longitudinal study. Menopause 2009; 16: 817-821
• 17 Mishra GD, Carrigan G, Brown WJ. et al. Short-term weight change and the incidence of diabetes in midlife: results from the Australian longitudinal study on women’s health. Diabetes Care 2007; 30: 1418-1424
• 18 Duval K, Prud’Homme D, Rabasa-Lhoret R. et al. Effects of the menopausal transition on energy expenditure: a MONET group study. Eur J Clin Nutr 2013; 67: 407-411
• 19 Pettee Gabriel K, Sternfeld B, Colvin A. et al. Physical activity trajectories during midlife and subsequent risk of physical functioning decline in late mid-life: the study of women’s health across the nation (SWAN). Prev Med 2017; 105: 287-294
• 20 Sternfeld B, Bhat AK, Wang H. et al. Menopause, physical activity, and body composition/fat distribution in midlife women. Med Sci Sports Exerc 2005; 37: 1195-1202
• 21 Irwin ML, Yasui Y, Ulrich CM. et al. Effect of exercise on total and intra-abdominal body fat in postmenopausal women: a randomized controlled trial. JAMA 2003; 289: 323-330
• 22 Van Gemert WA, Peeters PH, May AM. et al. Effect of diet with or without exercise on abdominal fat in postmenopausal women – a randomised trial. BMC Public Health 2019; 19: 174
• 23 Serra MC, Blumenthal JB, Addison OR. et al. Effects of weight loss with and without exercise on regional body fat distribution in postmenopausal women. Ann Nutr Metab 2017; 70: 312-320
• 24 Mandrup CM, Egelund J, Nyberg M. et al. Effects of high-intensity training on cardiovascular risk factors in premenopausal and postmenopausal women. Am J Obstet Gynecol 2017; 216: 384.e1-384.e11
• 25 Simkin-Silverman LR, Wing RR, Boraz MA. et al. Lifestyle intervention can prevent weight gain during menopause: results from a 5-year randomized clinical trial. Ann Behav Med 2003; 26: 212-220
• 26 Juppi H-K, Sipila S, Fachada V. et al. Total and regional body adiposity increases during menopause – evidence from a follow-up study. Aging Cell 2022; 21: e13621
• 27 Hyvärinen M, Juppi HK, Taskinen S. et al. Metabolic health, menopause, and physical activity – a 4-year follow-up study. Int J Obes (Lond) 2022; 46: 544-554
• 28 Ruiz-Rios M, Maldonado-Martin S.. Physical activity on cardiorespiratory fitness and cardiovascular risk in premenopausal and postmenopausal women: a systematic review of randomized controlled trials. Menopause 2022; 29: 1222-1229
• 29 Messier V, Rabasa-Lhoret R, Barbat-Artigas S. et al. Menopause and sarcopenia: a potential role for sex hormones. Maturitas 2011; 68: 331-336
• 30 Heymsfield SB, Gonzalez MCC, Shen W. et al. Weight loss composition is one-fourth fat-free mass: s critical review and critique of this widely cited rule. Obes Rev 2014; 15: 310-321
• 31 Ravussin E, Lillioja S, Anderson TE. et al. Determinants of 24-hour energy expenditure in man. methods and results using a respiratory chamber. J Clin Invest 1986; 78: 1568-1578
• 32 Bogardus C, Lillioja S, Ravussin E. et al. Familial dependence of the resting metabolic rate. N Engl J Med 1986; 315: 96-100
• 33 Godsland IF.. Oestrogens and insulin secretion. Diabetologia 2005; 48: 2213-2220
• 34 Yan H, Yang W, Zhou F. et al. Estrogen improves insulin sensitivity and suppresses gluconeogenesis via the transcription factor Foxo1. Diabetes 2019; 68: 291-304
• 35 Bruns CM, Kemnitz JW.. Sex hormones, insulin sensitivity, and diabetes mellitus. ILAR J 2004; 45: 160-169
• 36 Margolis KL, Bonds DE, Rodabough RJ. et al. Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the women’s health initiative hormone trial. Diabetologia 2004; 47: 1175-1187
• 37 Mauvais-Jarvis F, Manson JAE, Stevenson JC. et al. Menopausal hormone therapy and type 2 diabetes prevention: evidence, mechanisms, and clinical implications. Endocr Rev 2017; 38: 173-188
• 38 Houmard JA, Tanner CJ, Slentz CA. et al. Effect of the volume and intensity of exercise training on insulin sensitivity. J Appl Physiol (1985) 2004; 96: 101-106
• 39 Hawley JA, Lessard SJ.. Exercise training-induced improvements in insulin action. Acta Physiol (Oxf) 2008; 192: 127-135
• 40 Richter EA, Garetto LP, Goodman MN. et al. Muscle glucose metabolism following exercise in the rat. increased sensitivity to insulin. J Clin Invest 1982; 69: 785-793
• 41 Ross R, Janssen I, Dawson J. et al. Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obes Res 2004; 12: 789-798
• 42 Hansen PA, Nolte LA, Chen MM. et al. Increased GLUT-4 translocation mediates enhanced insulin sensitivity of muscle glucose transport after exercise. J Appl Physiol (1985) 1998; 85: 1218-1222
• 43 Bogardus C, Lillioja S, Mott DM. et al. Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol 1985; 248: E286-E291
• 44 Brown MD, Korytkowski MT, Zmuda JM. et al. Insulin sensitivity in postmenopausal women: independent and combined associations with hormone replacement, cardiovascular fitness, and body composition. Diabetes Care 2000; 23: 1731-1736
• 45 Frank LL, Sorensen BE, Yasui Y. et al. Effects of exercise on metabolic risk variables in overweight postmenopausal women: a randomized clinical trial. Obes Res 2005; 13: 615-625
• 46 Kim JW, Kim DY.. Effects of aerobic exercise training on serum sex hormone binding globulin, body fat index, and metabolic syndrome factors in obese postmenopausal women. Metab Syndr Relat Disord 2012; 10: 452-457
• 47 Choquette S, Riesco É, Cormier É. et al. Effects of soya isoflavones and exercise on body composition and clinical risk factors of cardiovascular diseases in overweight postmenopausal women: a 6-month double-blind controlled trial. Br J Nutr 2011; 105: 1199-1209
• 48 Mason C, Foster-Schubert KE, Imayama I. et al. Dietary weight loss and exercise effects on insulin resistance in postmenopausal women. Am J Prev Med 2011; 41: 366-375
• 49 Davidson LE, Hudson R, Kilpatrick K. et al. Effects of exercise modality on insulin resistance and functional limitation in older adults: a randomized controlled trial. Arch Intern Med 2009; 169: 122-131
• 50 Church TS, Blair SN, Cocreham S. et al. Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial. JAMA 2010; 304: 2253-2262
• 51 Ungvari Z, Tarantini S, Donato AJ. et al. Mechanisms of vascular aging. Circ Res 2018; 123: 849-867
• 52 Palmer RMJ, Ferrige AG, Moncada S.. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526
• 53 Holden DP, Cartwright JE, Nussey SS. et al. Estrogen stimulates dimethylarginine dimethylaminohydrolase activity and the metabolism of asymmetric dimethylarginine. Circulation 2003; 108: 1575-1580
• 54 Tan E, Gurjar MV., Sharma RV.. et al. Estrogen receptor-α gene transfer into bovine aortic endothelial cells induces eNOS gene expression and inhibits cell migration. Cardiovasc Res 1999; 43: 788-797
• 55 Darblade B, Pendaries C, Krust A. et al. Estradiol alters nitric oxide production in the mouse aorta through the α-, but not β-, estrogen receptor. Circ Res 2002; 90: 413-419
• 56 Best PJM, Berger PB, Miller VM. et al. The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women. Ann Intern Med 1998; 128: 285-288
• 57 Moreau KL, Hildreth KL, Meditz AL. et al. Endothelial function is impaired across the stages of the menopause transition in healthy women. J Clin Endocrinol Metab 2012; 97: 4692-4700
• 58 Lakatta EG, Levy D.. Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation 2003; 107: 346-354
• 59 Van Eickels M, Grohé C, Cleutjens JPM. et al. 17Β-estradiol attenuates the development of pressure-overload hypertrophy. Circulation 2001; 104: 1419-1423
• 60 Patten RD, Pourati I, Aronovitz MJ. et al. 17 beta-estradiol differentially affects left ventricular and cardiomyocyte hypertrophy following myocardial infarction and pressure overload. J Card Fail 2008; 14: 245-253
• 61 Lam CSP, Donal E, Kraigher-Krainer E, Vasan RS.. Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur J Heart Fail 2011; 13: 18-28
• 62 Lam CSP, Carson PE, Anand IS. et al. Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the irbesartan in heart failure with preserved ejection fraction (I-PRESERVE) trial. Circ Hear Fail 2012; 5: 571-578
• 63 Fukuma N, Takimoto E, Ueda K. et al. Estrogen receptor-α non-nuclear signaling confers cardioprotection and is essential to cGMP-PDE5 inhibition efficacy. JACC Basic Transl Sci 2020; 5: 282-295
• 64 Lewis TV., Dart AM, Chin-Dusting JPF. et al. Exercise training increases basal nitric oxide production from the forearm in hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 1999; 19: 2782-2787
• 65 Black MA, Cable NT, Thijssen DHJ. et al. Impact of age, sex, and exercise on brachial artery flow-mediated dilatation. Am J Physiol Hear Circ Physiol 2009; 297: H1109-H1116
• 66 Swift DL, Weltman JY, Patrie JT. et al. Predictors of improvement in endothelial function after exercise training in a diverse sample of postmenopausal women. J Women’s Heal 2014; 23: 260-266
• 67 Nyberg M, Egelund J, Mandrup CM. et al. Early postmenopausal phase is associated with reduced prostacyclin-induced vasodilation that is reversed by exercise training: the Copenhagen women study. Hypertension 2016; 68: 1011-1020
• 68 Pierce GL, Eskurza I, Walker AE. et al. Sex-specific effects of habitual aerobic exercise on brachial artery flow-mediated dilation in middle-aged and older adults. Clin Sci 2011; 120: 13-23
• 69 Santos-Parker JR, Strahler TR, Vorwald VM. et al. Habitual aerobic exercise does not protect against micro-or macrovascular endothelial dysfunction in healthy estrogen-deficient postmenopausal women. J Appl Physiol (1985) 2017; 122: 11-19
• 70 Moreau KL, Stauffer BL, Kohrt WM. et al. Essential role of estrogen for improvements in vascular endothelial function with endurance exercise in postmenopausal women. J Clin Endocrinol Metab 2013; 98: 4507-4515
• 71 Salzano A, De Luca M, Israr MZ. et al. Exercise intolerance in heart failure with preserved eEjection fraction. Heart Fail Clin 2021; 17: 397-413
• 72 Thurston RC.. Vasomotor symptoms: natural history, physiology, and links with cardiovascular health. Climacteric 2018; 21: 96-100
• 73 Kravitz HM, Kazlauskaite R, Joffe H.. Sleep, health, and metabolism in midlife women and menopause: food for thought. Obstet Gynecol Clin North Am 2018; 45: 679-694
• 74 Kline CE.. The bidirectional relationship between exercise and sleep: implications for exercise adherence and sleep improvement. Am J Lifestyle Med 2014; 8: 375-379
• 75 El Khoudary SR, Greendale G, Crawford SL. et al. The menopause transition and women’s health at midlife: a progress report from the study of women’s health across the nation (SWAN). Menopause 2019; 26: 1213-1227
• 76 Lambiase MJ, Thurston RC.. Physical activity and sleep among midlife women with vasomotor symptoms. Menopause 2013; 20: 946-952
• 77 Kline CE, Irish LA, Krafty RT. et al. Consistently high sports/exercise activity is associated with better sleep quality, continuity and depth in midlife women: the SWAN sleep study. Sleep 2013; 36: 1279-1288
• 78 Pettee Gabriel K, Mason JM, Sternfeld B.. Recent evidence exploring the associations between physical activity and menopausal symptoms in midlife women: perceived risks and possible health benefits. Womens Midlife Heal 2015; 1: 1
• 79 Kline CE, Sui X, Hall MH. et al. Dose-response effects of exercise training on the subjective sleep quality of postmenopausal women: exploratory analyses of a randomised controlled trial. BMJ Open 2012; 2: e001044
• 80 Mansikkamäki K, Raitanen J, Nygård CH. et al. Sleep quality and aerobic training among menopausal women – A randomized controlled trial. Maturitas 2012; 72: 339-345
• 81 Sternfeld B, Guthrie KA, Ensrud KE. et al. Efficacy of exercise for menopausal symptoms: a randomized controlled trial. Menopause 2014; 21: 330-338
• 82 Reed SD, Guthrie KA, Newton KM. et al. Menopausal quality of life: randomized controlled trial of yoga, exercise, and omega-3 supplements. Am J Obstet Gynecol 2014; 210: 244.e1-244.e11
• 83 Wilbur JE, Miller AM, McDevitt J. et al. Menopausal status, moderate-intensity walking, and symptoms in midlife women. Res Theory Nurs Pract 2005; 19: 163-180
• 84 Recker R, Lappe J, Davies K. et al. Characterization of perimenopausal bone loss: a prospective study. J Bone Miner Res 2000; 15: 1965-1973
• 85 Karlamangla AS, Burnett-Bowie SAM, Crandall CJ.. Bone health during the menopause transition and beyond. Obstet Gynecol Clin North Am 2018; 45: 695-708
• 86 Lorentzon M, Johansson H, Harvey NC. et al. Osteoporosis and fractures in women: the burden of disease. Climacteric 2022; 25: 4-10
• 87 Nazrun AS, Tzar MN, Mokhtar SA. et al. A systematic review of the outcomes of osteoporotic fracture patients after hospital discharge: morbidity, subsequent fractures, and mortality. Ther Clin Risk Manag 2014; 10: 937-948
• 88 Martyn-St. James M, Carroll S.. High-intensity resistance training and postmenopausal bone loss: a meta-analysis. Osteoporos Int 2006; 17: 1225-1240
• 89 Kelley GA, Kelley KS, Tran ZV.. Exercise and lumbar spine bone mineral density in postmenopausal women: a meta-analysis of individual patient data. J Gerontol A Biol Sci Med Sci 2002; 57: M599-M604
• 90 Wallace BA, Cumming RG.. Systematic review of randomized trials of the effect of exercise on bone mass in pre- and postmenopausal women. Calcif Tissue Int 2000; 67: 10-18
• 91 Kistler-Fischbacher M, Weeks BK, Beck BR.. The effect of exercise intensity on bone in postmenopausal women (part 2): a meta-analysis. Bone 2021; 143: 115697
• 92 Martyn-St James M, Carroll S.. Meta-analysis of walking for preservation of bone mineral density in postmenopausal women. Bone 2008; 43: 521-531
• 93 Shea KL, Gavin KM, Melanson EL. et al. Body composition and bone mineral density after ovarian hormone suppression with or without estradiol treatment. Menopause 2015; 22: 1045-1052
• 94 Gozansky WS, Van Pelt RE, Jankowski CM. et al. Protection of bone mass by estrogens and raloxifene during exercise-induced weight loss. J Clin Endocrinol Metab 2005; 90: 52-59
• 95 Villareal DT, Fontana L, Weiss EP. et al. Bone mineral density response to caloric restriction-induced weight loss or exercise-induced weight loss: a randomized controlled trial. Arch Intern Med 2006; 166: 2502-2510
• 96 Cheng MH, Wang SJ, Yang FY. et al. Menopause and physical performance - a community-based cross-sectional study. Menopause 2009; 16: 892-896
• 97 Da Câmara SMA, Zunzunegui MV, Pirkle C. et al. Menopausal status and physical performance in middle aged women: a cross-sectional community-based study in Northeast Brazil. PLoS One 2015; 10: e0119480
• 98 Schultz AB, Ashton-Miller JA, Alexander NB.. What leads to age and gender differences in balance maintenance and recovery?. Muscle Nerve 1997; 4: S60-S64
• 99 Marlatt KL, Redman LM, Beyl RA. et al. Racial differences in body composition and cardiometabolic risk during the menopause transition: a prospective, observational cohort study. Am J Obstet Gynecol 2020; 222: 365.e1-365.e18
• 100 Polotsky HN, Polotsky AJ.. Metabolic implications of menopause. Semin Reprod Med 2010; 28: 426-434
• 101 Hulteen RM, Smith JJ, Morgan PJ. et al. Global participation in sport and leisure-time physical activities: a systematic review and meta-analysis. Prev Med 2017; 95: 14-25
• 102 U.S. Department of Health and Human Services. Physical Activity Guidelines for Americans, 2nd edition. Department of Health and Human Services; Washington, DC: U.S: 2018
• 103 Fu S, Low Choy N, Nitz J.. Controlling balance decline across the menopause using a balance-strategy training program: a randomized, controlled trial. Climacteric 2009; 12: 165-176
• 104 Bromberger JT, Schott LL, Avis NE. et al. Psychosocial and health-related risk factors for depressive symptom trajectories among midlife women over 15 years: study of women’s health across the nation (SWAN). Psychol Med 2019; 49: 250-259
• 105 Bromberger JT, Schott LL, Kravitz HM. et al. Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the study of women’s health across the nation (SWAN). Arch Gen Psychiatry 2010; 67: 598-607
• 106 Dugan SA, Bromberger JT, Segawa E. et al. Association between physical activity and depressive symptoms: midlife women in SWAN. Med Sci Sports Exerc 2015; 47: 335-342
• 107 Cohen LS, Soares CN, Vitonis AF. et al. Risk for new onset of depression during the menopausal transition: the harvard study of moods and cycles. Arch Gen Psychiatry 2006; 63: 385-390
• 108 Woods NF, Smith-DiJulio K, Percival DB. et al. Depressed mood during the menopausal transition and early postmenopause: observations from the Seattle midlife women’s health study. Menopause 2008; 15: 223-232
• 109 Freeman EW, Sammel MD, Liu L. et al. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 2004; 61: 62-70
• 110 Blumenthal JA, Babyak MA, Moore KA. et al. Effects of exercise training on older patients with major depression. Arch Intern Med 1999; 159: 2349-2356
• 111 McLafferty CL, Wetzstein CJ, Hunter GR.. Resistance training is associated with improved mood in healthy older adults. Percept Mot Skills 2004; 98: 947-957
• 112 Weicker H, Strüder HK.. Influence of exercise on serotonergic neuromodulation in the brain. Amino Acids 2001; 20: 35-47